February 6, 2024
A key health ministry advisory panel on February 5 recommended label expansions for a batch of drugs including Ono Pharmaceutical’s anti-PD-1 antibody Opdivo (nivolumab) and Eli Lilly’s JAK inhibitor Olumiant (baricitinib). The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Second...read more